6-chloro-7-(1,3-dihydroisoindol-2-yl)-1-(2-fluoro-4-hydroxyphenyl)-4-oxoquinoline-3-carboxylic acid
C24H16ClFN2O4 — CID 167509393
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-7-(1,3-dihydroisoindol-2-yl)-1-(2-fluoro-4-hydroxyphenyl)-4-oxoquinoline-3-carboxylic acid
6-chloro-7-(1,3-dihydroisoindol-2-yl)-1-(2-fluoro-4-hydroxyphenyl)-4-oxoquinoline-3-carboxylic acid (PubChem CID 167509393) has the molecular formula C24H16ClFN2O4 and a molecular weight of 450.85 g/mol. Its IUPAC name is 6-chloro-7-(1,3-dihydroisoindol-2-yl)-1-(2-fluoro-4-hydroxyphenyl)-4-oxoquinoline-3-carboxylic acid.
Molecular Properties
| Compound Name | 6-chloro-7-(1,3-dihydroisoindol-2-yl)-1-(2-fluoro-4-hydroxyphenyl)-4-oxoquinoline-3-carboxylic acid |
|---|---|
| PubChem CID | 167509393 |
| Molecular Formula | C24H16ClFN2O4 |
| Molecular Weight | 450.85 g/mol |
| Exact Mass | 450.08 |
| IUPAC Name | 6-chloro-7-(1,3-dihydroisoindol-2-yl)-1-(2-fluoro-4-hydroxyphenyl)-4-oxoquinoline-3-carboxylic acid |
| SMILES | O=C(O)c1cn(-c2ccc(O)cc2F)c2cc(N3Cc4ccccc4C3)c(Cl)cc2c1=O |
| InChI | InChI=1S/C24H16ClFN2O4/c25-18-8-16-21(9-22(18)27-10-13-3-1-2-4-14(13)11-27)28(12-17(23(16)30)24(31)32)20-6-5-15(29)7-19(20)26/h1-9,12,29H,10-11H2,(H,31,32) |
| InChIKey | GONWVFYNFMPADW-UHFFFAOYSA-N |
| XLogP | 4.71 |
| TPSA | 82.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.85 |
| LogP ≤ 5 | 4.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167509393 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.